On Jun. 22, 2021, BioReference Laboratories, an OPKO Health company, announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal Caribbean Group, helping provide a safe environment for travelers.

Unvaccinated guests were required to undergo rapid, point-of-care PCR COVID-19 prior to embarking. These guests also underwent rapid, COVID-19 point-of-care testing at the end of their voyage, before disembarking. Testing also took place on board, during the cruise.